<DOC>
	<DOCNO>NCT02987036</DOCNO>
	<brief_summary>The purpose study find weather difference administration nebulizer technology ( Jet nebulizer VS. mesh nebulizer ) impact lung mechanic variable ( Compliance , resistance PEEPi ) control mechanical ventilation .</brief_summary>
	<brief_title>Delivery Beta Agonists Technique Sensitive ( DOBATS ) Mechanics</brief_title>
	<detailed_description>The delivery aerosols two fold appeal distribute direct tracheo- bronchial tree alveolar epithelium . The drug rapidly absorb circulation avoid first pas entero-hepatic metabolic effect . The systemic effect may regard side effect case primary therapeutic target aim bronchial tree case broncho-active drug , β2-stimulants . The ability particles remain suspended gas predict size , shape density , couple density viscosity gas . The property aerosol commonly express Mass Median Aerosol Diameter MMAD , measure average particle size geometric standard deviation . It calculate cumulative particle size curve1 . The MMAD give reliable estimate likely deposition drug along tracheo-bronchial tree . A particle size &gt; 5 likely deposit upper airway , particle MMAD 2-5 likely deposit tracheo-bronchial tree2 . Jet nebulizer commonly use device aerosol therapy . However , MMAD generate device unpredictable , often leading drug deposit ventilator circuit endotracheal tube3 . An alternative vibrating mesh nebulizer , base high frequency vibrate piezoelectric crystal . The crystal vibrate micron mesh high frequency . A micro pump deliver small volume liquid reservoir vibrate mesh result precise aerosol generation3 . Nebulizer therapy often prescribe without proven effect proper evaluation result . Indeed , two large multicenter trial acute lung injury patient discontinue interim analysis due lack effect4,5 . This lack effect may due nebulizer technology ( Jet nebulizer ) , indication ( ARDS ) , primary outcome . The investigator would like compare difference therapeutic effect two device publish previously . It well know physical property generate aerosol may differ widely , depend device technology use . Hence , even amount drug administer , distribution uptake . It expect therapeutic response different .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Patients mechanical ventilation 48 hour PEEPi ≥3 cm H2O expect remain controlled mechanical ventilation least 24 hour . Severe chronic lung disease chronic hypercapnia ( PCO2 &gt; 45 mm Hg ) , Chronic hypoxemia ( PO2 &lt; 55mm Hg FiO2=0,21 ) , hospitalization within last 6 month respiratory failure ( PCO2 &gt; 50 ; PO2 &lt; 55mm Hg ) , Secondary polycythemia , severe pulmonary hypertension ( mPAP &gt; 40 mm Hg . Unable obtain consent Acute myocardial infarction Severe congestive heart failure Heart rate great maximal predict heart rate MHR85 ( MHR 85=0.85 x ( 220age ) . Burns 40 % body surface area Cancer irreversible disease condition 6month mortality estimate great 50 % Allogenic bone marrow transplantation within 5 year prior study Diffuse alveolar hemorrhage vaculitis Morbid obesity Moribund , expect survive 24 hour Daily use beta agonist prior hospitalization Participation study Chronic liver disease Neuromuscular disease impair ability breath without assistance ( e.g . Cervical spine cord injury level C5 high , Amyotrophic lateral sclerosis , GuillainBarre syndrome myasthenia gravis ) Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>nebulizer technology , lung mechanic , beta-agonistic drug</keyword>
</DOC>